BASF has sold its San Diego-based bioenergy enzymes business, including the Spartec® product portfolio and technologies in development, to Lallemand subsidiaries, Danstar Ferment AG and Lallemand Specialties Inc. Lallemand will integrate the business and associated employees in its Lallemand Biofuels & Distilled Spirits (LBDS) business unit.

LBDS has partnered with BASF’s bioenergy business since 2017, jointly developing the expression of gluco and alpha amylase enzymes in bioengineered yeast, now widely used in the North American ethanol production market.

“We see the capabilities of BASF’s bioenergy team and its Spartec® products and pipeline technologies as highly complementary with ours,” said Angus Ballard, President and General Manager of LBDS. “By combining resources and R&D programs, we will be even better placed to meet our global customers’ requirements.”

LBDS will present its expanded portfolio at the Fuel and Ethanol Workshop (FEW) next week in Minneapolis.